BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 32056182)

  • 1. MicroRNAs: A novel signature in the metastasis of esophageal squamous cell carcinoma.
    Wei QY; Jin F; Wang ZY; Li BJ; Cao WB; Sun ZY; Mo SJ
    World J Gastroenterol; 2024 Mar; 30(11):1497-1523. PubMed ID: 38617454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEIS1 promotes expression of stem cell markers in esophageal squamous cell carcinoma.
    Zargari S; Negahban Khameneh S; Rad A; Forghanifard MM
    BMC Cancer; 2020 Aug; 20(1):789. PubMed ID: 32819319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematical identification of key genes and regulatory genetic variants associated with prognosis of esophageal squamous cell carcinoma.
    Gu L; Yue X; Niu S; Ma J; Liu S; Pan M; Song L; Su Q; Tan Y; Li Y; Chang J
    Mol Carcinog; 2024 Jun; 63(6):1013-1023. PubMed ID: 38380955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and clinical implications of metastasis-associated circular RNAs in oesophageal squamous cell carcinoma.
    Fang X; Shrestha SM; Ren LH; Shi RH
    FEBS Open Bio; 2021 Nov; 11(11):2870-2887. PubMed ID: 34510785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive analysis of mRNA expression profiles of Esophageal Squamous Cell Carcinoma reveals downregulation of Desmoglein 1 and crucial genomic targets.
    Alotaibi A; Gadekar VP; Gundla PS; Mandarthi S; Ravi S; Mallya D; Tungekar A; Lavanya BV; Bhagavath AK; Cordero MW; Pitkaniemi J; Seetharam RN; Bepari A; Hebbar P
    Cancer Biomark; 2023; 38(4):465-487. PubMed ID: 38073377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy number variations in esophageal squamous cell carcinoma: Emerging cancer drivers and biomarkers (Review).
    Ren J; Kong P; Wang Y; Guo D; Zhang L
    Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of Chinese oesophageal squamous cell carcinoma identifies novel subtypes associated with distinct clinical outcomes.
    Liu M; An H; Zhang Y; Sun W; Cheng S; Wang R; Wang X; Feng L
    EBioMedicine; 2020 Jul; 57():102831. PubMed ID: 32580137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the molecular mechanisms of microRNA‑409‑3p in tumor progression: Towards targeted therapeutics (Review).
    Xie W; Wang Z; Wang J; Wang X; Guan H
    Int J Oncol; 2024 Jul; 65(1):. PubMed ID: 38757364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNAs as Noninvasive Biomarkers and Therapeutic Agents of Pituitary Adenomas.
    Beylerli O; Beeraka NM; Gareev I; Pavlov V; Yang G; Liang Y; Aliev G
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulated miRNAs in osteoporosis: effects in bone metastasis.
    Bellavia D; Salamanna F; Raimondi L; De Luca A; Carina V; Costa V; Alessandro R; Fini M; Giavaresi G
    Cell Mol Life Sci; 2019 Oct; 76(19):3723-3744. PubMed ID: 31147752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging role of microRNA-22 in the Leukemia: experimental and clinical implications.
    Xia J; Bu C; Zhang B; Wang X; Chen Y; Li T
    Mol Biol Rep; 2023 Dec; 51(1):12. PubMed ID: 38085373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Importance of Standardization on Analyzing Circulating RNA.
    Lee I; Baxter D; Lee MY; Scherler K; Wang K
    Mol Diagn Ther; 2017 Jun; 21(3):259-268. PubMed ID: 28039578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Crosstalk Between Autophagy and MicroRNAs in Esophageal Carcinoma:
    Gorjizadeh N; Poudineh S; Barghgir B; Eghbali M; Sarlak A; Poudineh M
    Galen Med J; 2023; 12():e2903. PubMed ID: 37808004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research and clinical applications of molecular biomarkers in gastrointestinal carcinoma (Review).
    Jiao F; Jin Z; Wang L; Wang L
    Biomed Rep; 2013 Nov; 1(6):819-827. PubMed ID: 24649035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of hub microRNAs dysregulated in esophageal squamous cell carcinoma.
    Sang C; Chao C; Wang M; Zhang Y; Luo G; Zhang X
    Aging (Albany NY); 2020 May; 12(10):9807-9824. PubMed ID: 32412911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA circ-SLC7A5 Functions as a Competing Endogenous RNA to Impact Cell Biological Behaviors in Esophageal Squamous Cell Carcinoma (ESCC).
    Wang L; Hong Z
    Cell Biochem Biophys; 2024 Mar; 82(1):139-151. PubMed ID: 37814151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel circ_0001946/miR-1290/SOX6 ceRNA network in esophageal squamous cell cancer.
    Wang J; Yao W; Li J; Zhang Q; Wei L
    Thorac Cancer; 2022 May; 13(9):1299-1310. PubMed ID: 35411716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics.
    Abe I; Lam AK
    Curr Oncol Rep; 2021 Feb; 23(3):31. PubMed ID: 33582932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of MicroRNAs in Esophageal Squamous Cell Carcinoma Pathogenesis.
    Islam F; Gopalan V; Lam AK
    Methods Mol Biol; 2020; 2129():241-257. PubMed ID: 32056182
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.